IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.453
EU - Europa 2.679
AS - Asia 1.742
OC - Oceania 7
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 8.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.439
CN - Cina 1.045
PL - Polonia 934
UA - Ucraina 546
FR - Francia 323
SG - Singapore 286
IT - Italia 220
DE - Germania 219
HK - Hong Kong 165
FI - Finlandia 110
TR - Turchia 92
IE - Irlanda 87
GB - Regno Unito 86
IN - India 78
RU - Federazione Russa 75
SE - Svezia 37
VN - Vietnam 25
KR - Corea 22
CA - Canada 14
ID - Indonesia 13
BE - Belgio 12
NL - Olanda 8
AU - Australia 7
CZ - Repubblica Ceca 7
EU - Europa 6
IR - Iran 6
LT - Lituania 4
MU - Mauritius 4
AT - Austria 2
CL - Cile 2
ES - Italia 2
IM - Isola di Man 2
JP - Giappone 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
GR - Grecia 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 8.896
Salva come PNG Salva come JPEG
Città #
Warsaw 933
Fairfield 722
Woodbridge 552
Houston 432
Shenzhen 403
Jacksonville 394
Ashburn 317
Cambridge 274
Seattle 268
Wilmington 264
Ann Arbor 245
Singapore 224
Princeton 166
Hong Kong 163
Brescia 141
Beijing 135
Chandler 133
Nanjing 118
New York 111
Dublin 85
Dearborn 79
Istanbul 71
Nanchang 69
Moscow 50
Shenyang 46
Helsinki 43
San Diego 36
Des Moines 34
Changsha 32
Hebei 32
Jinan 31
Dong Ket 24
Tianjin 24
Jiaxing 20
London 20
Seongnam 19
Taizhou 19
Milan 18
Ningbo 18
San Francisco 17
Shanghai 16
Kunming 14
Jakarta 13
Kocaeli 13
Toronto 12
Verona 12
Hangzhou 10
Zhengzhou 10
Brussels 9
Munich 9
Augusta 8
Haikou 8
Lancaster 7
Phoenix 7
Boardman 6
Sydney 6
Brno 5
Leawood 5
Mcallen 5
Monmouth Junction 5
Norwalk 5
Ardabil 4
Chiswick 4
Guangzhou 4
Lanzhou 4
Los Angeles 4
Washington 4
Amsterdam 3
Kilburn 3
Orange 3
Taiyuan 3
Aberdare 2
Acton 2
Baotou 2
Barcelona 2
Charlotte 2
Chicago 2
Cluj-Napoca 2
Douglas 2
Frankfurt am Main 2
Lappeenranta 2
Lumezzane 2
Marcheno 2
Oklahoma City 2
Olginate 2
Redmond 2
Riyadh 2
Romola 2
San Benedetto Po 2
San Mateo 2
Seoul 2
Vobarno 2
Waanrode 2
Athens 1
Bandar Seri Begawan 1
Bangkok 1
Bologna 1
Borgosatollo 1
Brooklyn 1
Canberra 1
Totale 7.054
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 521
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 295
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 288
NFKB1 regulates human NK cell maturation and effector functions 281
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 248
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 244
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 237
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 218
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 159
The RAC2-PI3K axis regulates human NK cell maturation and function 155
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 145
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 143
CTLA-4 regulates human Natural Killer cell effector functions 138
Inherited DOCK2 deficiency in patients with early-onset invasive infections 129
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 129
Effects of opioid therapy on human natural killer cells. 123
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 116
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 114
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 113
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 110
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 109
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 108
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 108
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 108
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 107
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 107
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 105
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 105
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 104
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 103
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 101
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 101
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 100
Flow cytometric detection of total and serine 473 phosphorylated Akt. 100
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 100
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 99
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 99
Nuclear apoptotic changes: an overview 96
The emerging multiple roles of nuclear Akt 95
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 94
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 94
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 93
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 92
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 92
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 92
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 90
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 90
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 87
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 87
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 86
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 86
Nuclear changes in necrotic HL-60 cells. 85
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 84
Nuclear lipids: new functions for old molecules? 81
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 79
Further considerations on the intranuclear distribution of HMGI/Y proteins. 77
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 75
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 73
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 72
P85α is an intrinsic regulator of human natural killer cell effector functions 70
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 68
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 68
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 68
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 68
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 67
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 62
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 61
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 60
The controversial nuclear matrix: a balanced point of view. 60
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 59
Molecular characterization of protein kinase C-alpha binding to lamin A. 58
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 57
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 57
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 56
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 56
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 55
Natural killer cell impairment in ovarian clear cell carcinoma 53
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 52
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 50
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 48
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 48
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 43
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 41
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 40
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 35
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 31
FGF-trapping hampers cancer stem-like cells in uveal melanoma 18
Totale 9.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.236 0 0 0 0 0 0 252 272 182 306 96 128
2020/20211.437 32 141 31 259 63 138 69 146 200 130 168 60
2021/2022827 61 158 21 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/20241.004 36 11 462 27 17 130 32 25 163 2 8 91
2024/2025469 11 3 6 184 155 110 0 0 0 0 0 0
Totale 9.079